openPR Logo
Press release

Keratoconus Treatment Market 2018 Expected To Reach 427.5 Million USD By The End Of 2023 | Top Key Players - HOYA Vision Care, Johnson & Johnson Vision Care, Inc., Menicon Co., Ltd., Novartis AG, Optik Seis and Others

01-04-2019 07:23 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Market Research Future

Keratoconus Treatment Market

Keratoconus Treatment Market

MRFR is the Leading Brand in The Research Company who Recently Published Keratoconus TreatmentMarket Research Reports which includes Study of growth, Regional Analysis, Top Industry Players Formation, Major Drivers, Upcoming Trends and Forecast to 2023.

Market Scenario:

The Global Keratoconus Treatment Market has been evaluated as a rapidly growing market and it is expected to continue growing in the near future.

Approximately 3 million people are affected by this disease across the globe. Advanced diagnostic and treatment options are key drivers for this market. Increasing awareness of the disease, increasing funding for R&D and growing demand from emerging regions such as Asia are major driving forces of the market. Major players of this market are investing in R&D to develop effective solution for keratoconus. Introduction of wide range of lenses is important factor for market growth.

The market for keratoconus treatment was around USD 322.7 million in 2016 and is expected to reach USD 427.5 million by 2023 which is a projected CAGR of 4.1%.

Keratoconus KC is a condition of the eye which results in liberal thinning of the cornea. This may result in blurry vision, double vision, near sightedness, astigmatism, and light sensitivity. Usually both eyes are affected. In more severe cases a scarring or a circle may be seen within the cornea. While the cause is unknown, it is thought to occur due to a combination of genetic, environmental, and hormonal factors.

Further about seven percent of those affected have a family history of the condition, proposed environmental factors comprise of rubbing eyes and allergies. The fundamental mechanism involves changes of the cornea to a cone shape. Diagnosis is by examination with a slit lamp.

Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/3861

Moreover initially the condition can typically be corrected with glasses or soft contact lenses. As the disease worsens special contact lenses may be required. In most people the disease stabilizes after a few years without severe vision problems. In a small number of Keratoconus KC is a condition of the eye which results in liberal thinning of the cornea. This may result in blurry vision, double vision, near sightedness, astigmatism, and light sensitivity. Usually both eyes are affected. In more severe cases a scarring or a circle may be seen within the cornea. While the cause is unknown, it is thought to occur due to a combination of genetic, environmental, and hormonal factors.

Further about seven percent of those affected have a family history of the condition, proposed environmental factors comprise of rubbing eyes and allergies. The fundamental mechanism involves changes of the cornea to a cone shape. Diagnosis is by examination with a slit lamp.

The global keratoconus treatment market has been evaluated as a rapidly growing market and it is expected to continue growing in the near future.

Approximately 3 million people are affected by this disease across the globe. Advanced diagnostic and treatment options are key drivers for this market. Increasing awareness of the disease, increasing funding for R&D and growing demand from emerging regions such as Asia are major driving forces of the market. Major players of this market are investing in R&D to develop effective solution for keratoconus. Introduction of wide range of lenses is important factor for market growth. people scarring of the cornea occurs and a corneal transplantation is required

Key players for Global Keratoconus Treatment Market:

Some of the key players in this market are: Bausch & Lomb Incorporated (US), CIBA VISION (US), CooperVision (US), HOYA Vision Care (Singapore), Johnson & Johnson Vision Care, Inc. (US), Menicon Co., Ltd. (Japan), Novartis AG (Switzerland), Optik Seis (Indonesia), and SAFILENS S.R.L. (Italy), and others.

Segments:

Global keratoconus treatment market has been segmented on the basis of type which comprises of forme fruste keratoconus, corneal hydrops, keratoglobus, pellucid marginal degeneration, posterior keratoconus, and others.

On the basis of end user, it is segmented into eye hospitals & clinics, medical research centers, academic institutes, and others.

On the basis of diagnosis, the market is segmented into computerized corneal mapping, keratometry, slit-lamp examination, refraction test, and others. Slit-lamp examination includes tonometry, vision testing, and others.

On the basis of treatments, the market has been segmented into lenses, surgery, collagen cross-linking, and others. Lenses is sub-segmented into eyeglasses or soft contact lenses, hard contact lenses, piggyback lenses, hybrid lenses, scleral lenses, and others. Surgery is sub-segmented into corneal inserts, cornea transplant, and others. Collagen cross-linking is still in research process and more study is required to implement this treatment option.

Regional

Considering the global scenario of the market, America is the highest revenue generator with North American region contributing the most. North America mainly includes US and Canada. US is one of the dominant markets not only in America but also in the global market. European market is the second largest and UK is believed to be the fastest growing market for keratoconus treatment in this region. Increasing awareness, growing purchasing power, and rapidly improving healthcare sector are driving the growth for Asia Pacific keratoconus market. Asia Pacific is one of the high potential market for keratoconus treatment. Due to slow adoption of new treatments and prosucts, Middle East and Africa is expected to grow at steady pace.

Browse Complete 80 Pages Premium Research Report Enabled with Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/keratoconus-treatment-market-3861

Detailed Table of Contents:

1 Report Prologue

2 Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

2.3 Market Structure

2.4. Market Segmentation

3 Research Methodology

3.1 Research Process

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

3.5 Forecast Model

...Continued!

Send an Enquiry @ https://www.marketresearchfuture.com/enquiry/3861

About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Keratoconus Treatment Market 2018 Expected To Reach 427.5 Million USD By The End Of 2023 | Top Key Players - HOYA Vision Care, Johnson & Johnson Vision Care, Inc., Menicon Co., Ltd., Novartis AG, Optik Seis and Others here

News-ID: 1470293 • Views:

More Releases from Market Research Future

Intravenous (IV) Solution Market Set to Grow to USD 26.60 Billion at 7.70% CAGR by 2032
Intravenous (IV) Solution Market Set to Grow to USD 26.60 Billion at 7.70% CAGR …
Market Overview: The Intravenous (IV) Solution Market is estimated to be valued at USD 13.9 billion in 2023 and is projected to reach USD 26.60 billion by 2032, expanding at a compound annual growth rate (CAGR) of 7.70% from 2024 to 2031. The market growth is attributed to the rising prevalence of chronic diseases, growing hospitalization rates, and increasing surgical procedures that require IV fluid administration. Intravenous solutions are critical
Laboratory Equipment Market Projected to Reach USD 102.11 Billion with 7.66% CAGR by 2032
Laboratory Equipment Market Projected to Reach USD 102.11 Billion with 7.66% CAG …
Market Overview: The Laboratory Equipment Market is estimated to be valued at USD 49.6 billion in 2024 and is projected to reach USD 78.2 billion by 2031, growing at a compound annual growth rate (CAGR) of 6.7% from 2024 to 2031. The market growth is primarily driven by the rising demand for advanced research tools in pharmaceuticals, biotechnology, clinical diagnostics, and academic institutes. Increasing investment in R&D activities, coupled with technological
Medical Second Opinion Market Set to Grow to USD 21.36 Billion at a 14.30% CAGR by 2034
Medical Second Opinion Market Set to Grow to USD 21.36 Billion at a 14.30% CAGR …
Market Overview: The Medical Second Opinion Market is estimated to grow significantly from 2024 to 2031, driven by the rising need for accurate diagnosis, treatment validation, and better patient care. A second opinion helps patients make more informed healthcare decisions, particularly in cases of complex surgeries, rare diseases, or chronic illnesses. With increasing awareness among patients about medical errors and the importance of exploring alternative treatments, the demand for medical second
Penicillin Drug Market Forecasted to Surpass USD 14.36 Billion at a 3.64% CAGR by 2034
Penicillin Drug Market Forecasted to Surpass USD 14.36 Billion at a 3.64% CAGR b …
Market Overview: The Penicillin Drug Market is estimated to be valued significantly in 2024 and is projected to grow steadily, reaching a substantial valuation by 2031. This growth is driven by the continued reliance on penicillin as a frontline antibiotic and its wide therapeutic applications in bacterial infection management. Penicillin remains one of the most widely prescribed antibiotics globally, with demand sustained by rising bacterial infection prevalence, increasing healthcare expenditure, and

All 5 Releases


More Releases for Keratoconus

08-06-2025 | Health & Medicine
Getnews
Valley Optometry Eyecare Broadens Awareness Around Reseda Keratoconus Treatment …
Image: https://www.globalnewslines.com/uploads/2025/08/1754401929.jpg Valley Optometry Eyecare remains a steady presence in the Los Angeles eye care landscape, recognised for its careful, technology-driven approach to diagnosis and long-term treatment. Operating at the intersection of clinical precision and patient accessibility, the centre continues to address lesser-known but increasingly prevalent conditions affecting local vision health. Among these concerns, keratoconus stands out for its complexity and the subtlety of its onset. Affecting the shape and strength of
05-27-2025 | Health & Medicine
Getnews
Valley Optometry Eyecare Provides Breakthrough Keratoconus Therapy
Image: https://www.globalnewslines.com/uploads/2025/05/1748342525.jpg Valley Optometry Eyecare stands at the forefront of advanced eye care for Southern California residents. The practice operates from its central location with modern equipment and highly trained staff ready to tackle complex vision problems. Eye health specialists at this established center work tirelessly to address conditions many patients fear might permanently affect their sight. Valley Optometry Eyecare has earned trust within the community through consistent results and attention
Keratoconus and Orthokeratology Solutions Available at Valley Optometry Eyecare …
Image: https://www.globalnewslines.com/uploads/2025/03/1742807130.jpg Vision loss is more than just an inconvenience-it can rob people of their independence, confidence, and ability to perform even the simplest daily tasks. For those suffering from progressive conditions like Keratoconus or seeking non-surgical vision correction through Orthokeratology, the struggle to maintain clear eyesight can be overwhelming. Valley Optometry Eyecare Center offers specialized solutions to restore clarity, comfort, and control to patients facing these challenges. Keratoconus is a progressive
Keratoconus Treatment Market Size, Share, Trends, Growth and Competitive Analysi …
"Keratoconus Treatment Market report is an important manuscript for every market enthusiast, policymaker, investor, and market player. A detailed market research study of this report focuses on several essential parameters related to the market that includes but are not limited to a competitive landscape, brief segmentation and industrial infrastructure. This marketing report offers an in-depth overview of product specification, technology, product type and production analysis considering major factors such as
Keratoconus Market Size, Share, Trends And Forecast To 2034
How big is the keratoconus market? The keratoconus market reached a value of US$ 202.1 Million in 2023 and expected to reach US$ 275.0 Million by 2034, exhibiting a growth rate (CAGR) of 2.84% during 2024-2034. The report offers a comprehensive analysis of the keratoconus market in the United States, EU5 (including Germany, Spain, Italy, France, and the United Kingdom), and Japan. It covers aspects such as treatment methods, drugs available in
Keratoconus Market Size, Growth, Research Report & Trends 2023-2033
Keratoconus Market Report Overview:   Report Attribute Details Base Year